
1. bioorg med chem lett. 2001 sep 3;11(17):2235-9.

evolution anti-hiv drug candidates. part 3: diarylpyrimidine (dapy) analogues.

ludovici dw(1), de corte bl, kukla mj, ye h, ho cy, lichtenstein ma, kavash rw,
andries k, de b√©thune mp, azijn h, pauwels r, lewi pj, heeres j, koymans lm, de
jonge mr, van aken kj, daeyaert ff, das k, arnold e, janssen pa.

author information: 
(1)janssen research foundation, welsh mckean roads, spring house, pa 19477,
usa.

the synthesis anti-hiv-1 activity series diarylpyrimidines (dapys)
are described. several members novel class non-nucleoside reverse
transcriptase inhibitors (nnrtis) extremely potent wild-type and
a panel clinically significant single- double-mutant strains hiv-1.

doi: 10.1016/s0960-894x(01)00412-7 
pmid: 11527705  [indexed medline]

